Fundraising FoxSarentis Therapeutics
New York, US · Delaware corporation
Find your way into Sarentis Therapeutics
Sign up to see every warm intro you have to Sarentis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sarentis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DB
Denise BarbutFounder, Chairman and CEO2010–2015Denise Barbut held faculty and leadership positions in neurology at Cornell University, including a role directing stroke research, and has founded and led biotech companies.
Reported raises · per SEC filings
Form D private placements$750K disclosed across 1 round · 2015
▶$750KraisedJul 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$750KraisedJul 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Denise BarbutExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $750K
- Minimum investment
- $100K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Sarentis Therapeutics?
- Sarentis Therapeutics was founded by Denise Barbut.
- How much funding has Sarentis Therapeutics raised?
- Sarentis Therapeutics has disclosed $750K raised across 1 round.
- Where is Sarentis Therapeutics headquartered?
- Sarentis Therapeutics is headquartered in New York, US.